Both in Surgical Instruments
SS Innovations International vs Neuropace
Over the past year SSII returned −71.2% and NPCE returned +45.9%; their daily moves had a correlation of 0.03.
SSII −71.2% NPCE +45.9%Growth of $1, one year, split-adjusted
| Metric | SSII | NPCE |
|---|---|---|
| Price | $2.26 | $13.71 |
| Market cap | $453.5M | $470.6M |
| Today | −2.92% | +11.37% |
| 1 month | −18.0% | +8.2% |
| 6 months | −44.4% | −24.3% |
| Year to date | −60.2% | −11.2% |
| 1 year | −71.2% | +45.9% |
| Revenue growth (YoY) | +39.4% | +17.1% |
| Gross margin | 50.9% | 82.8% |
| Net margin | −19.1% | −27.2% |
| P/E (TTM) | — | — |
| Price / sales | 8.7× | 4.8× |
| Net cash | -$987.5K | -$7.3M |
| Dividend yield | — | — |
| Volatility (60d) | 46.0% | 46.0% |
| Short % of float | 0.2% | 3.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).